Palandri, Francesca; Iacobucci, Ilaria; Martinelli, Giovanni; Amabile, Marilina; Poerio, Angela; Testoni, Nicoletta; Soverini, Simona; Castagnetti, Fausto; DE VIVO, Antonio; Breccia, M; Specchia, G; Abruzzese, E; Martino, B; Cilloni, D; Saglio, G; Pane, F; Liberati, Am; Rosti, Gianantonio; Baccarani, Michele; GIMEMA Working Party on, C. M. L., Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML., «JOURNAL OF CLINICAL ONCOLOGY», 2008, 26, pp. 106 - 111 [Scientific article]
Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papayannidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M., New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib, in: Haematology Meeting Reports, «HEMATOLOGY MEETING REPORTS», 2008, 2, pp. 27 - 32 (atti di: New Drugs in Hematology, Bologna, 5-7 ottobre 2008) [Contribution to conference proceedings]
S. Soverini; G. Martinelli; A. Vitale; A. Gnani; .S Colarossi; S. Paolini; I. Iacobucci; C. Papayannidis; M. Vignetti; A. Lonetti; L. Elia; G Leone; M. Lazzarino; G. Torelli; R. Fanin; G. Cimino; G. Meloni; A. Guarini; F. Mandelli; M. Baccarani; R. Foà, Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Already Harbor Bcr-Abl Kinase Domain Mutations at Low Levels at the Time of Diagnosis - a Report by the GIMEMA ALL Working Party, in: Blood, «BLOOD», 2008, 112 (11), pp. 722 - 722 (atti di: 50th ASH Annual Meeting, San Francisco, CA, Dec. 6-9, 2008) [Abstract]
Iacobucci, Ilaria; Lonetti, Annalisa; Ottaviani, Emanuela; Cilloni, Daniela; Messa, Francesca; Paolini, Stefania; Papayannidis, Cristina; Pier Paolo Piccaluga, ; Giannoulia, Panagiota; Soverini, Simona; Amabile, Marilina; Saglio, Giuseppe; Pane, Fabrizio; Berton, Giorgio; Baruzzi, Anna; Vitale, Antonella; Foa, Robin; Baccarani, Michele; Martinelli, Giovanni, The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors, in: Volume 68, Issue 9 Supplement, «CANCER RESEARCH», 2008, 68, pp. 5515 - 5515 (atti di: AACR Annual Meeting, San Diego, CA, Apr 12-16, 2008) [Abstract]
Castagnetti F.; Palandri F.; Gugliotta G.; Poerio A.; Amabile M.; Soverini S.; Martinelli G.; Baccarani M.; Rosti G., Thyrosin kinase inhibitors: nilotinib, «HEMATOLOGY MEETING REPORTS», 2008, 2 (5), pp. 22 - 26 [Scientific article]
Martinelli G.; Soverini S.; Iacobucci I., What we don’t know about resistance to tyrosine kinase inhibitors in CML: what makes CML cells a tougher enemy than expected?, «CLINICAL LEUKEMIA», 2008, 2, pp. 86 - 87 [Scientific article]
Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B., Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients, «LEUKEMIA RESEARCH», 2007, 31, pp. 163 - 167 [Scientific article]
Rosti, Gianantonio; Iacobucci, Ilaria; Bassi, Simona; Castagnetti, Fausto; Amabile, Marilina; Cilloni, D; Poerio, A; Soverini, Simona; Palandri, Francesca; Rege Cambrin, G; Iuliano, F; Alimena, G; Latagliata, R; Testoni, Nicoletta; Pane, F; Saglio, G; Baccarani, Michele; Martinelli, Giovanni, Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party., «HAEMATOLOGICA», 2007, 92, pp. 101 - 105 [Scientific article]
Iacobucci I; Galletti L; Amabile M; Soverini S; Baccarani M; Martinelli G., Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio, «HAEMATOLOGICA», 2007, 92, pp. 429 - 430 [Scientific article]
Martinelli G.; Iacobucci I.; Soverini S.; Palandri F.; Castagnetti F.; Rosti G.; Baccarani M., Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance, «BIOLOGICS», 2007, 1, pp. 121 - 127 [Scientific article]Open Access
Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G., Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain, «HAEMATOLOGICA», 2007, 92, pp. 401 - 404 [Scientific article]
Soverini S.; Baccarani M.; Iacobucci I.; Martinelli G., Resistance to tyrosine kinase inhibitors in Philadelphia chromosome-positive leukemias: which mutations matter?, «CLINICAL LEUKEMIA», 2007, 1, pp. 223 - 228 [Scientific article]
Soverini S; Martinelli G; Colarossi S; Gnani A; Rondoni M; Castagnetti F; Paolini S; Rosti G; Baccarani M., Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL, «THE LANCET ONCOLOGY», 2007, 8, pp. 273 - 274 [Scientific article]
Soverini S; Iacobucci I; Baccarani M; Martinelli G., Targeted therapy and the T315I mutation in Philadelphia-positive leukemias., «HAEMATOLOGICA», 2007, 92, pp. 437 - 439 [Scientific article]
Baccarani M; Cilloni D; Rondoni M; Ottaviani E; Messa F; Merante S; Tiribelli M; Buccisano F; Testoni N; Gottardi E; de Vivo A; Giugliano E; Iacobucci I; Paolini S; Soverini S; Rosti G; Rancati F; Astolfi C; Pane F; Saglio G; Martinelli G., The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study., «HAEMATOLOGICA», 2007, 92, pp. 1173 - 1179 [Scientific article]
